Radiosensitizing Effects of Lithium Ascorbate on Normal and Tumor Lymphoid Cells under X-ray Irradiation

Q2 Pharmacology, Toxicology and Pharmaceutics Current Bioactive Compounds Pub Date : 2023-10-01 DOI:10.2174/1573407219666230503094421
E. Plotnikov, Maria S Tretayakova, Konstantin S. Brazovskii, M. Belousov, A. Artamonov, S. Stuchebrov, A. Gogolev, M. Larkina, E. Sukhikh
{"title":"Radiosensitizing Effects of Lithium Ascorbate on Normal and Tumor\nLymphoid Cells under X-ray Irradiation","authors":"E. Plotnikov, Maria S Tretayakova, Konstantin S. Brazovskii, M. Belousov, A. Artamonov, S. Stuchebrov, A. Gogolev, M. Larkina, E. Sukhikh","doi":"10.2174/1573407219666230503094421","DOIUrl":null,"url":null,"abstract":"\n\nThe study aimed to assess the radiosensitizing effect of lithium ascorbate on tumor cells.\n\n\n\nCancer cells radioresistance is an important factor restraining the success of X-ray\ntherapy. Radiosensitizing drugs make tumor cells more sensitive to ionizing radiation and improve\nthe effectiveness of radiotherapy. Although many chemical substances can potentiate the cytotoxic\neffects of X-ray radiation, their clinical applications are limited due to possible adverse reactions.\nRecently, several approaches have been proposed to develop new radiosensitizers that are highly\neffective and feature low toxicity. Among new enhancers of X-ray therapy, ascorbic acid, and its\nderivates demonstrate very low toxicity along with a wide therapeutic range. Lithium ascorbate is a\npromising X-ray therapy enhancer, but its mechanism of action is unknown. This research focuses\non the radiosensitizing properties of lithium ascorbate and its effects on both tumor and normal irradiated\ncells.\n\n\n\nThe viability of the radiosensitized cells was evaluated by fluorescence flow cytometry\nusing Annexin V-FITC Apoptosis Detection Kit and Cellular ROS Assay Kit (Abcam, UK). The\ntest cell cultures included normal human mononuclear and Jurkat cells.\n\n\n\nLithium ascorbate sensitizes normal human mononuclear and Jurkat cells towards ionizing\nradiation. The combined cytotoxic effect of X-ray irradiation (3 Gy) and lithium ascorbate (1,2\nmmol/L) substantially exceeds the effects of the individual factors, i.e. synergetic action appears.\nThe major types of cell death were late apoptosis and necrosis caused by excessive production of\nreactive oxygen species.\n\n\n\nLithium ascorbate in combination with X-ray irradiation exhibited the cytotoxic effect\non both normal and cancer lymphoid cells by activating reactive oxygen species (ROS)-induced\napoptosis. These findings indicate that lithium ascorbate is a promising substance to develop a new\nradiosensitizing drug.\n","PeriodicalId":10772,"journal":{"name":"Current Bioactive Compounds","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioactive Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573407219666230503094421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1

Abstract

The study aimed to assess the radiosensitizing effect of lithium ascorbate on tumor cells. Cancer cells radioresistance is an important factor restraining the success of X-ray therapy. Radiosensitizing drugs make tumor cells more sensitive to ionizing radiation and improve the effectiveness of radiotherapy. Although many chemical substances can potentiate the cytotoxic effects of X-ray radiation, their clinical applications are limited due to possible adverse reactions. Recently, several approaches have been proposed to develop new radiosensitizers that are highly effective and feature low toxicity. Among new enhancers of X-ray therapy, ascorbic acid, and its derivates demonstrate very low toxicity along with a wide therapeutic range. Lithium ascorbate is a promising X-ray therapy enhancer, but its mechanism of action is unknown. This research focuses on the radiosensitizing properties of lithium ascorbate and its effects on both tumor and normal irradiated cells. The viability of the radiosensitized cells was evaluated by fluorescence flow cytometry using Annexin V-FITC Apoptosis Detection Kit and Cellular ROS Assay Kit (Abcam, UK). The test cell cultures included normal human mononuclear and Jurkat cells. Lithium ascorbate sensitizes normal human mononuclear and Jurkat cells towards ionizing radiation. The combined cytotoxic effect of X-ray irradiation (3 Gy) and lithium ascorbate (1,2 mmol/L) substantially exceeds the effects of the individual factors, i.e. synergetic action appears. The major types of cell death were late apoptosis and necrosis caused by excessive production of reactive oxygen species. Lithium ascorbate in combination with X-ray irradiation exhibited the cytotoxic effect on both normal and cancer lymphoid cells by activating reactive oxygen species (ROS)-induced apoptosis. These findings indicate that lithium ascorbate is a promising substance to develop a new radiosensitizing drug.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗坏血酸锂对X射线照射下正常和肿瘤淋巴细胞的放射增敏作用
本研究旨在评估抗坏血酸锂对肿瘤细胞的放射增敏作用。癌症细胞的放射抵抗是制约X射线治疗成功的重要因素。放射增敏药物使肿瘤细胞对电离辐射更敏感,提高了放射治疗的有效性。尽管许多化学物质可以增强X射线辐射的细胞毒性,但由于可能的不良反应,它们的临床应用受到限制。最近,人们提出了几种方法来开发高效低毒的新型放射增敏剂。在新的X射线治疗促进剂中,抗坏血酸及其衍生物表现出非常低的毒性和广泛的治疗范围。抗坏血酸锂是一种很好的X射线治疗促进剂,但其作用机制尚不清楚。本研究的重点是抗坏血酸锂的放射增敏特性及其对肿瘤和正常照射细胞的影响。使用Annexin V-FITC细胞凋亡检测试剂盒和细胞ROS测定试剂盒(Abcam,UK)通过荧光流式细胞术评估放射增敏细胞的活力。测试细胞培养物包括正常人单核细胞和Jurkat细胞。抗坏血酸锂使正常人单核细胞和Jurkat细胞对电离辐射敏感。X射线照射(3 Gy)和抗坏血酸锂(1,2mmol/L)的联合细胞毒性作用大大超过了单个因素的影响,即出现协同作用。细胞死亡的主要类型是由活性氧的过量产生引起的晚期细胞凋亡和坏死。抗坏血酸锂与X射线照射相结合,通过激活活性氧(ROS)诱导的细胞凋亡,对正常和癌症淋巴细胞均表现出细胞毒性作用。这些发现表明抗坏血酸锂是开发一种新的放射增敏药物的有前途的物质。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Bioactive Compounds
Current Bioactive Compounds Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.90
自引率
0.00%
发文量
112
期刊介绍: The journal aims to provide comprehensive review articles on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia. The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.
期刊最新文献
Investigation on the Potential of Some N-phenylalkanehydrazides as Superoxide Anion Radical Scavengers and Glutathione Peroxidase Binders with ADME Prediction: Comparison with Vitamin C Chemistry or Hypoglycaemic Aspect of Thiazolidin-2,4-Dione Insight into the Structure-activity Relationship Unveiling the Potential of Piper cubeba L. f.: A Comprehensive Review Covering its Phytochemistry, Pharmacology, and Cutting-edge Applications Influence of Parameters of Mechanochemical Processing on the Efficacy of Complex Solid Dispersion of Anthelmintics Cucurbitacin: Unveiling its Role as Phytomolecule in Health Benefits
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1